EP3297617A4 - Homogenous cannabis compositions and methods of making the same - Google Patents

Homogenous cannabis compositions and methods of making the same Download PDF

Info

Publication number
EP3297617A4
EP3297617A4 EP16796872.6A EP16796872A EP3297617A4 EP 3297617 A4 EP3297617 A4 EP 3297617A4 EP 16796872 A EP16796872 A EP 16796872A EP 3297617 A4 EP3297617 A4 EP 3297617A4
Authority
EP
European Patent Office
Prior art keywords
homogenous
making
methods
same
cannabis compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16796872.6A
Other languages
German (de)
French (fr)
Other versions
EP3297617A1 (en
Inventor
Jeremy H. GOLDSTEIN
Justin Eric SINGER
Adrian VERWOLF
Garret Nicodemus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
5071 Inc
Original Assignee
5071 Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 5071 Inc filed Critical 5071 Inc
Priority claimed from PCT/US2016/025044 external-priority patent/WO2016186735A1/en
Publication of EP3297617A1 publication Critical patent/EP3297617A1/en
Publication of EP3297617A4 publication Critical patent/EP3297617A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/06—Treating tea before extraction; Preparations produced thereby
    • A23F3/14—Tea preparations, e.g. using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP16796872.6A 2015-05-18 2016-03-30 Homogenous cannabis compositions and methods of making the same Pending EP3297617A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562163316P 2015-05-18 2015-05-18
PCT/US2016/025044 WO2016186735A1 (en) 2015-05-18 2016-03-30 Homogenous cannabis compositions and methods of making the same

Publications (2)

Publication Number Publication Date
EP3297617A1 EP3297617A1 (en) 2018-03-28
EP3297617A4 true EP3297617A4 (en) 2019-02-20

Family

ID=61223555

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16796872.6A Pending EP3297617A4 (en) 2015-05-18 2016-03-30 Homogenous cannabis compositions and methods of making the same

Country Status (1)

Country Link
EP (1) EP3297617A4 (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136752A1 (en) * 2001-02-14 2002-09-26 Gw Pharmaceuticals Limited Pharmaceutical formulations
CN101904401A (en) * 2010-07-09 2010-12-08 云南龙润茶业集团有限公司 Tea jelly sweet
US20110092583A1 (en) * 2005-11-07 2011-04-21 Murty Pharmaceuticals, Inc. Oral Dosage Form Of Tetrahydrocannabinol And A Method Of Avoiding And/Or Suppressing Hepatic First Pass Metabolism Via Targeted Chylomicron/Lipoprotein Delivery
CN103110582A (en) * 2013-03-04 2013-05-22 上海医药工业研究院 Cannabinol compound micro-emulsion and preparation method thereof
US20150045282A1 (en) * 2008-10-31 2015-02-12 The University Of Mississippi Compositions containing delta-9-thc-amino acid esters and process of preparation
US20150057341A1 (en) * 2013-08-22 2015-02-26 Stephen C. Perry Composition with Pharmacological Effect for Vaporizing and Method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136752A1 (en) * 2001-02-14 2002-09-26 Gw Pharmaceuticals Limited Pharmaceutical formulations
US20110092583A1 (en) * 2005-11-07 2011-04-21 Murty Pharmaceuticals, Inc. Oral Dosage Form Of Tetrahydrocannabinol And A Method Of Avoiding And/Or Suppressing Hepatic First Pass Metabolism Via Targeted Chylomicron/Lipoprotein Delivery
US20150045282A1 (en) * 2008-10-31 2015-02-12 The University Of Mississippi Compositions containing delta-9-thc-amino acid esters and process of preparation
CN101904401A (en) * 2010-07-09 2010-12-08 云南龙润茶业集团有限公司 Tea jelly sweet
CN103110582A (en) * 2013-03-04 2013-05-22 上海医药工业研究院 Cannabinol compound micro-emulsion and preparation method thereof
US20150057341A1 (en) * 2013-08-22 2015-02-26 Stephen C. Perry Composition with Pharmacological Effect for Vaporizing and Method

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 201381, Derwent World Patents Index; AN 2013-R00947, XP002787597 *

Also Published As

Publication number Publication date
EP3297617A1 (en) 2018-03-28

Similar Documents

Publication Publication Date Title
EP3478308A4 (en) Cannabis compositions and methods
EP3337823A4 (en) Carrier-binding agent compositions and methods of making and using the same
EP3352774A4 (en) Flavonoid compositions and methods of use
EP3352577A4 (en) Cannabinoid compositions and methods of making
EP3230441A4 (en) Compositions and methods for the production of scaav
EP3268018A4 (en) Bacterial compositions and methods of use thereof
EP3393655A4 (en) Fenfluramine compositions and methods of preparing the same
EP3435956A4 (en) Photo-stabilized compositions and methods of use
EP3268370A4 (en) Antimicrobial compounds and methods of making and using the same
EP3532633A4 (en) Compositions and methods for the production of compounds
EP3186286A4 (en) Cellulose-containing compositions and methods of making same
EP3503879A4 (en) Compositions and methods thereof
EP3166892A4 (en) Scale-inhibition compositions and methods of making and using the same
EP3386927A4 (en) Polymer compositions and methods of use
EP3436083A4 (en) Novel compositions and methods
IL264386B1 (en) New cannabis tablet formulations and compositions and methods of making the same
EP3307756A4 (en) Methods and compositions for cannabis characterization
EP3423404A4 (en) New germanosilicate compositions and methods of preparing the same
EP3110891A4 (en) Low-voc compositions and methods of making and using the same
EP3253403A4 (en) Methods and compositions for improved cognition
EP3137479A4 (en) Oligonucleotide compositions and methods of making the same
EP3334579A4 (en) Discontinuous-fiber composites and methods of making the same
EP3532055A4 (en) Compositions and methods for the production of compounds
EP3551619A4 (en) Compositions comprising methylphenidate-prodrugs, processes of making and using the same
EP3316871A4 (en) Talc-bound compositions and uses thereof

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171215

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/10 20060101ALI20190109BHEP

Ipc: A61K 31/05 20060101ALI20190109BHEP

Ipc: A23L 2/52 20060101ALI20190109BHEP

Ipc: A61K 9/16 20060101AFI20190109BHEP

Ipc: A61K 31/352 20060101ALI20190109BHEP

Ipc: A23F 3/14 20060101ALI20190109BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20190118

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20230102